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Abstract: Genome-scale metabolic models are of high interest in a number of different research
fields. Flux balance analysis (FBA) and other mathematical methods allow the prediction of the
steady-state behavior of metabolic networks under different environmental conditions. However,
many existing applications for flux optimizations do not provide a metabolite-centric view on fluxes.
Metano is a standalone, open-source toolbox for the analysis and refinement of metabolic models.
While flux distributions in metabolic networks are predominantly analyzed from a reaction-centric
point of view, the Metano methods of split-ratio analysis and metabolite flux minimization also allow
a metabolite-centric view on flux distributions. In addition, we present MMTB (Metano Modeling
Toolbox), a web-based toolbox for metabolic modeling including a user-friendly interface to Metano
methods. MMTB assists during bottom-up construction of metabolic models by integrating reaction
and enzymatic annotation data from different databases. Furthermore, MMTB is especially designed
for non-experienced users by providing an intuitive interface to the most commonly used modeling
methods and offering novel visualizations. Additionally, MMTB allows users to upload their models,
which can in turn be explored and analyzed by the community. We introduce MMTB by two use
cases, involving a published model of Corynebacterium glutamicum and a newly created model of
Phaeobacter inhibens.
Keywords: systems biology; metabolic modeling; flux balance analysis; Phaeobacter inhibens;
tropodithietic acid
1. Introduction
Genome-scale metabolic models are important tools for systems biology. They are
used in various fields, e.g. in metabolic engineering, the identification of potential drug
targets, and as knowledge libraries to understand the behavior of biological systems in
detail [1]. In these applications, mathematical methods are essential for the calculation of
flux distributions in large networks.
Flux balance analysis (FBA) allows the prediction of the steady-state condition of the
metabolic network of an organism under different environmental conditions [2]. Metabolic
networks typically have more reactions than metabolites, which results in an under-
determined solution space. The standard approach to solve the under-determined system
is to apply linear programming. In this approach, constraints are added to reduce the
solution space. The optimal solution is one that maximizes or minimizes a given objective
function, e.g. biomass production. The underlying assumption is that the organism has
been optimized through evolution for a biological goal, such as optimal growth or minimal
nutrient uptake [3]. In contrast, minimization of metabolic adjustment (MOMA) is used to
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calculate the flux distribution for perturbed networks, such as in knock-out mutants [4].
Due to the perturbation of the network, the assumption of FBA that the organism is evolved
for a biological goal may not be valid. The underlying assumption of MOMA is that the
organism undergoes a minimal redistribution of the network. For this reason, MOMA
employs quadratic programming to find a solution that is closest to the wild-type flux
distribution. Flux variability analysis (FVA) is an approach for analyzing the robustness
of a metabolic network [5]. FVA is used to find the minimal and maximal flux for each
reaction in the network while constraining some states of the flux distribution, e.g. limiting
the biomass production flux to at least 95% of the FBA maximum.
As most applications for flux optimization focus on a reaction-centric point of view,
they pay little attention to metabolite fluxes. Only a small number of previous studies
showed the benefit of analyzing models from a metabolite-centric point of view, e.g. for the
discovery of new drugs [6,7]. There are also algorithms that maximize specific metabolite
fluxes for the calculation of metabolic changes in order to predict the effect of certain
drugs [8]. However, these methods were never integrated into a comprehensive modeling
toolbox and can only be reproduced by experts in programming and metabolic modeling.
Metabolic modeling is used for a variety of applications, ranging from biotechnologi-
cal applications to ecological questions [9]. A well-characterized marine model organism
is Phaeobacter inhibens DSM 17395, an ideal model organism for basic research and elu-
cidation of stress responses because of its metabolic versatility. Experimental data for
degradation pathways of different carbon sources based on metabolome and proteome
measurements have been determined for P. inhibens DSM 17395 in previous studies by us
and others [10–14]. The organism carries three extrachromosomal elements (65 kb, 78 kb
and 262 kb) [15,16]. Proteins required for the biosynthesis of the antibacterial compound
tropodithietic acid (TDA) are encoded on one of them [15,17,18]. Deletion of the plasmids
leads to large variations in the growth efficiency with amino acids as a carbon source [19].
More recently, we could show that the main reason for higher growth yields of the ∆262-kb
plasmid-cured mutant strain are higher non-growth-associated energy requirements of the
wild-type strain because its antibiotic TDA disturbs the membrane proton gradient [20,21].
Thus, wild-type and TDA-negative mutant strains of P. inhibens DSM 17395 are applicable
for metabolic modeling.
The second model system of this study is Corynebacterium glutamicum DSM 20300,
a widely used biotechnological production strain that was originally isolated as an L-
glutamate-producing bacterium [22] and is used to produce about 2.5 million tons of
glutamate per year [23]. Furthermore, C. glutamicum has been metabolically engineered for
the production of other amino acids, organic acids, alcohols, and polymers [23].
In this study, we present Metano, an open-source command-line toolbox for metabolic
modeling, and MMTB, a web-based interface to Metano that comes with an integrative
database of biochemical reactions and genome annotations. While Metano was developed
for a more versed audience, MMTB was designed especially for inexperienced users or
users without a strong background in bioinformatics.
We applied Metano methods to the published model of C. glutamicum to verify the
accuracy or capability of the toolbox. In a second step, we used the TDA-negative mutant
strains of P. inhibens DSM 17395, with optimal growth on three different amino acids to re-
construct a metabolic model for P. inhibens DSM 17395, based on genomic and experimental
data. FBA was performed to analyze the carbon flux in the wild-type strain compared to
the TDA-negative mutant strains with respect to carbon loss and growth inhibition by TDA.
MMTB methods provided a metabolite-centric view on the model to determine changes in
the intracellular carbon flux under different growth conditions.
2. Results
2.1. Metano Standalone Toolbox
Metano is a Python-based command-line tool for the analysis of stoichiometric models.
Several features can be accessed online via the MMTB. Prominent examples of constraint-
Metabolites 2021, 11, 113 3 of 13
based metabolic modeling software include COBRA [24], FASIMU [25], OptFlux [26], and
FAME [27]. The freely available COBRA Toolbox [24] includes a continuously expanding
range of algorithms for flux optimization and metabolic engineering. COBRA is a MATLAB
toolbox, which also provides interfaces in Python [28] and other languages. Being the most
popular tool in this research field, we chose the COBRA toolbox for comparison (Table 1).
The command-line oriented software FASIMU [25] also has broad functionality. It offers
batch computation and introduces concentration-based thermodynamic feasibility as a
constraint. OptFlux [26] offers a graphical user interface, a broad range of features, and
many metabolic engineering tools, which makes it better suited for biotechnologists than
the other toolboxes. FAME [27] is an example of an exclusively web-based software solution.
It allows the user to create, edit, and run metabolic models in an online application. FAME
also supplies visualization of analysis results on KEGG-like maps.
Table 1. Feature comparison between Metano and existing software. Divided by horizontal lines
are different sections: functionality, usability, visualization, exchangeability, compatibility, and
assistance in model reconstruction. FBA: flux balance analysis; FVA: flux variability analysis; MOMA:
minimization of metabolic adjustment; ROOM: regulatory on-off minimization; MFM: metabolite
flux minimization; GUI: graphical user interface.
Feature Metano COBRA FASIMU OptFlux FAME
FBA + + + + +
FVA + + + + +
MOMA + + + + -
ROOM - - + + -
MFM + - - - -
Batch computation + - + - -
OptKnock - + - + -
Command line + + + - -
GUI for modeling - - - + -
Independence of commercial software + - + + +
Dynamic visualization GUI + - - - -
Static image + + - + +
External visualization software - - + - -
SBML import + + + + +
SBML export + + + + +
Text file import + - + + -
MATLAB export + + - - -
Linux + - + + *
MacOS + + + - *
Windows - + - + *
Pathway import from relational database + - - - +
Model verification + + - - -
Automated gap filling - + + - -
Notes: Feature comparison of programs for flux balance optimization. + and - indicate the existence and absence
of the feature, respectively. * No installation is needed, since FAME is exclusively web-based software.
While flux distributions in metabolic networks are conventionally analyzed from a
reaction-centric point of view, the Metano methods of split-ratio analysis and metabo-
lite flux minimization (MFM) allow a metabolite-centric view on flux distributions [29].
Split-ratio analysis gives insight into all reactions that are involved in the production
or consumption of a specific metabolite. MFM is a useful tool for the determination of
the essentiality of metabolites for optimal biomass production and flux distributions at
branch points. Additionally, a ranking of all metabolites by their minimal flux can give
further insights into the behavior of the metabolic network and the role of each metabolite
within. Metano also supports dynamic network visualization, utilizing the optional add-on
AMEBA [29]. This tool provides an interactive graphical user interface, which allows
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the user to navigate through the metabolic network by clicking on different nodes in the
bipartite reaction graph. AMEBA provides an integrated metabolite-centric view with
split-ratios of each metabolite that can be used for the refinement of genome-scale metabolic
models [29].
The Metano toolbox includes several features for flux optimization and is optimized
for processing speed. In addition to the common FBA algorithm, Metano implements the
fastFVA algorithm for FVA [30]. Metabolic flux minimization (MFM) is very similar to
FVA and is also amenable to the fastFVA strategy, but in a metabolite-centric approach.
MOMA has been implemented with the option to perform an FVA-based reduction of the
solution space as a preprocessing step, which can speed up the analysis significantly. In
the implementations of all the above-mentioned algorithms, iterative dead-end analysis
is performed prior to the respective optimization problem. This is done to reduce the
dimension of the solution space, hence reducing the calculation time substantially. Due to
its efficient run-time, Metano has been applied to large-scale analyses involving hundreds
of thousands of simulations [31–36]. The toolbox was proven to be able to handle larger
models with more than one thousand reactions and multiple compartments, e.g. the
iND750 model of Saccharomyces cerevisiae [37].
In addition to the widely used SBML format, Metano models can be represented
by simple lists of reactions that are readable by humans and can be easily modified by
the user with any text editor. An additional parameter file sets the constraints for a
simulation scenario so that the variables, e.g., substrate boundaries and objective function,
are detached from the model itself. Easy exchange of models is ensured by offering export
and import tools for the widely accepted standard format SBML [38].
2.2. MMTB Website
Metano Modeling Toolbox (MMTB) is a web-based tool for the generation and analysis
of metabolic models. MMTB closes the gap between BKMS-react [39] and EnzymeDetec-
tor [40,41]: biochemical reactions from BKMS-react are associated with genome annotations
from EnzymeDetector and preprocessed for use in metabolic modeling. Information on
metabolite structures and synonyms and the assembly of reactions into pathways support
bottom-up model generation. Additionally, MMTB allows OS-independent analyses and
visualization of metabolic models: an interface to the modeling toolbox Metano provides
different analysis methods and a metabolite-centric view of networks.
On the one hand, MMTB assists during model creation. The key feature is an intuitive
search tool that gives access to reaction and metabolite information. The user can search
for reactions by either entering parts of the biochemical reaction, EC numbers, database
IDs, or by selecting a BRENDA, MetaCyc, or KEGG pathway. The resulting reactions
originate from the integrative database BKMS-react [39] that includes all reactions from
BRENDA [41], KEGG [42], MetaCyc [43], and SABIO-RK [44]. MMTB shows ready-to-use
reactions and further information, e.g., the assigned EC numbers, database IDs, associated
pathways, and further links. Selected pathways are further visualized as a bipartite graph
(Figure 1). When the user selects an organism from a dropdown list, MMTB displays a
confidence score for the annotation of each enzymatic reaction. This score comes from
EnzymeDetector, which integrates genome annotations from different resources [41]. All
reactions can be downloaded in a plain reaction file for use with the Metano command-line
tool. Additionally, the user can search for metabolite synonyms and receive informa-
tion on recommended names, synonyms, molecular weight, and the chemical structure.
Metabolites can also be identified by using regular expressions.
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Figure 1. Screenshot of the output of a pathway search on MMTB. The selected pathway was L-leucine degradation (from 
MetaCyc) and the selected organism was Phaeobacter inhibens DSM 17395. MMTB informs about annotated enzymes 
from this pathway (A). Users can either download the whole pathway (B) or copy single reactions to the clipboard (C). 
MMTB shows annotation confidence scores for each enzyme that catalyzes this reaction, as well as the corresponding 
UniProt accession on mouse over (D). Reactions are cross-linked to other databases (E). Missing enzymes are highlighted 
in the reaction table (F). The color code in the bipartite graph also indicates the presence and absence (G) of enzymes, 
suggesting that this certain pathway is not present in the selected organism. 
On the other hand, MMTB assists during model analysis via an interface to the 
Metano toolbox. The user can upload a metabolic model and apply one of the following 
analysis methods: (1) FBA, (2) FVA, (3) dead-end analysis, (4) split-ratio analysis, (5) 
metabolite flux minimization, (6) a metabolite-centric visualization that shows the 
Figure 1. Screenshot of the output of a pathway search on MMTB. The selected pathway was L-leucine degradation (from
MetaCyc) and the selected organism was P aeobacter inhibens DSM 17395. MMTB informs bout annotat d enzymes
this pathw y (A). Users can either download the whole pathway (B) or copy single reactions to the clipboard (C). MMTB
shows annotation confidence scores for each enzyme that catalyzes this reaction, as well as the corresponding UniProt
accession on mouse over (D). Reactions are cross-linked to other databases (E). Missing enzymes are highlighted in the
reaction table (F). The color code in the bipartite graph also indicates the presence and absence (G) of enzymes, suggesting
that this certain pathway is not present in the selected organism.
On the other hand, MMTB assists during model analysis via an interface to the Metano
toolbox. The user can upload a metabolic model and apply one of the following analysis
methods: (1) FBA, (2) FVA, (3) dead-end analysis, (4) split-ratio analysis, (5) metabolite flux
minimization, (6) a metabolite-centric visualization that shows the network as an interactive
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bipartite graph with consuming and producing metabolite fluxes, (7) a model verification
tool where all metabolites in the uploaded model are replaced by their recommended
names from BKMS-react. Because misspelled metabolites or synonyms are not treated as
identical metabolic nodes, this unique method helps to avoid mistakes.
Additionally, MMTB has a model exchange platform, where users can upload and pub-
lish their own models. These models can be viewed, analyzed, visualized, and downloaded,
thus promoting the reuse of models that are already published. A model conversion tool for
SBML and JSON models allows the use of models that were generated with other software.
2.3. The Metabolic Model of Corynebacterium Glutamicum
The Metano modeling toolbox was evaluated using the published C. glutamicum model
iMG481 that consists of 550 reactions [45]. The online conversion tool of MMTB was used
to convert the model from SBML into the human-readable Metano plain text format. The
model was then uploaded to the MMTB modeling platform.
By using the Metano toolbox, we were able to reproduce the in silico growth on glucose
as it was described by Graf and colleagues. When using maximal biomass production as
objective function, Metano was able to reproduce the growth rate of 0.337 h−1, as well as
key fluxes described in the paper. Furthermore, the MFM method revealed that of a total
of 408 metabolites, 195 were not essential for biomass production of 95% of the optimal
value. When the biomass function is restricted to 10%, 205 metabolites are non-essential.
2.4. The Metabolic Model iPin571 and Biological Implications
The model iPin571 was manually assembled with the assistance of the MMTB database
of metabolic reactions and the integrated EnzymeDetector annotation (Supplementary
Table S1). The model was published under Creative Commons Attribution License and is
available on the MMTB modeling platform. The model consists of 486 genes, 571 metabolic
reactions (13 not sequence-based, 7 spontaneous), 35 transport reactions, 22 exchange
reactions, and 564 metabolites. The biomass reaction was divided into 17 reactions overall,
which allows an easy adaptation of the model to change biomass compositions. The model
includes all necessary biosynthesis pathways and energy metabolism. Additionally, degra-
dation pathways of amino acids, carbohydrates, and certain further carbon sources were
implemented based on experimentally determined metabolome and proteome data [10–14].
TDA biosynthesis is represented by an overall reaction, starting from the phenylalanine
degradation product 3-oxo-5,6-dehydrosuberyl-CoA semialdehyde, as the details of the
biosynthesis pathway are still not fully understood [17,18,46].
Nine of the proteinogenic amino acids were previously analyzed with respect to
growth physiology and degradation pathways [10]. For the analysis of the influence of TDA
production on the metabolism, three different amino acids were chosen: (1) L-phenylalanine
as the precursor for TDA biosynthesis, (2) L-alanine as an amino acid with immediate
access to the central carbon metabolism, and (3) L-leucine as an amino acid with a more
complex degradation pathway, slower growth, and a reduced TDA production compared
to L-alanine. TDA-negative strains (∆262-kb plasmid-cured and tdaE transposon mutant
strains) were cultivated as a reference to compare optimal growth with inhibited growth,
and furthermore, to analyze the influence of carbon loss due to secreted metabolites.
The model iPin571 was able to simulate growth for the TDA-negative mutants on
different carbon sources and the wild-type strain on leucine (Table 2).
The wild-type strain showed the lowest growth yields on each of the amino acids as
a nutrient, especially on L-phenylalanine, indicating reduced carbon yields due to TDA
biosynthesis (Supplementary Table S2). Growth yields of about 11–15 g molC−1 were
reached with TDA-negative mutant strains, similar to the growth yield of the ∆262-kb
plasmid-cured mutant strain with casamino acids as carbon source [19]. The growth
yield of the ∆262-kb mutant strain was about 1.7-fold (L-alanine), 1.3-fold (L-leucine),
and 1.6-fold (L-phenylalanine) higher compared to that of the wild-type strain. The tdaE
transposon mutant strain showed almost the same growth yields as the ∆262-kb mutant
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strain, indicating that the lower growth yields of the wild-type strain were connected to
the inhibitory effect of TDA with a necessity for an increased respiratory activity resulting
in more carbon loss by CO2 production [20,21].
Table 2. Experimentally determined and predicted growth rates. Experimentally determined specific







WT 5.7 0.160 0.239
∆262 5.6 0.235 0.231
tdaE 8.2 0.333 0.342
Phenylalanine
WT 1.4 0.102 0.159
∆262 1.4 0.170 0.161
tdaE 1.1 0.120 0.116
Leucine
WT 0.9 0.063 0.062
∆262 1.4 0.104 0.103
tdaE 1.5 0.123 0.114
The model was used to predict the carbon loss caused by TDA production. In absence
of TDA production, growth rates of P. inhibens DSM 17395 varied with the three amino
acids due to different specific uptake rates (Table 2). However, with active TDA biosynthe-
sis, specific uptake rates were higher, correlating with lower biomass yields. Without TDA
production, about 50% of the carbon was used for biomass production and about 50% was
respired to CO2 (Table 3).
Table 3. Predicted carbon flux distribution dependent on the carbon source. Listed are the theoretical
carbon flux distributions in % of the available carbon. FBAs were performed with experimentally
determined specific uptake rates and growth rates (Table 2).
Amino Acid Strain % Cell Dry Weight % CO2 % TDA
Alanine
WT 34.1 51.1 14.8
∆262 51.0 49.0 0
tdaE 52.5 47.5 0
Phenylalanine
WT 31.6 49.5 18.9
∆262 49.5 50.5 0
tdaE 49.6 50.4 0
Leucine
WT 45.5 54.5 0
∆262 51.0 49.0 0
tdaE 50.7 49.3 0
The wild-type flux distribution was similar to the mutant only when growing on
L-leucine as a carbon source, because very low amounts of TDA are produced under this
condition. With L-alanine and L-phenylalanine, only 32–34% of the available carbon was
used for biomass production, while 15–19% of the available carbon was used for TDA
production. However, due to the inhibitory effect by degrading the proton gradient [20,21],
a higher CO2 production could be possible.
We used the metabolite-centric view of MMTB to analyze the different growth behaviors
of the wild type. The analysis showed that while growing on L-phenylalanine, 21.5% of the
carbon source is converted into TDA (Figure 2). When growing on L-alanine, 0.72 mmol
gCDW−1 h−1 of prephenate, a precursor of phenylalanine, is synthesized. Only 8% of prephen-
ate is further converted to L-phenylalanine, while 92% is used to produce TDA. The total
amount of produced TDA is similar under both conditions. In contrast, when using L-leucine
as a carbon source, no TDA is produced, resulting in a total flux through prephenate of
0.03 mmol gCDW−1 h−1 and a higher carbon yield compared to the other conditions.
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Figure 2. Metabolite-centered visualization of split-ratio analyses of the branch point between phenylalanine degradation 
and TDA biosynthesis. Reaction nodes are shown in light blue and labelled with the E.C. number if available. Metabolite 
nodes are shown in dark blue and the blue labels at the metabolite nodes are absolute metabolite fluxes in mmol g CDW−1 
h−1. Edge labels between substrate and enzyme refer to relative fluxes outcoming from the metabolite, labels between 
enzyme and products refer to relative incoming fluxes of the metabolite. Grey parts of the network are inactive under the 
shown condition. Multiple reactions without branch points were condensed into dark blue dashed arrows. (A) simulation 
of wild type growth on L-alanine; (B) simulation of wild type growth on L-phenylalanine; (C) simulation of the tdaE mutant 
on L-phenylalanine. 
  
Figure 2. Metabolite-centered visualization of split-ratio analyses of the branch point between
phenylalanine degradation and TDA biosynthesis. Reaction nodes are shown in light blue and
labelled with the E.C. number if available. Metabolite nodes are shown in dark blue and the blue
labels at the metabolite nodes are absolute metabolite fluxes in mmol g CDW−1 h−1. Edge labels
b twee substrate and enzyme refer to relative fluxes outcoming from the metabolite, labels between
e zyme and products refer to relative inc ming fluxes of th metabolite. Grey parts of the network
are inactive under the shown condition. Multiple reactions without branch points were condensed
into dark blue dashed arrows. (A) simulation of wild type growth on L-alanine; (B) simulation of
wild type growth on L-phenylalanine; (C) simulation of the tdaE mutant on L-phenylalanine.
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3. Discussion
In this study, we presented Metano, a standalone toolbox for metabolic modeling.
Metano provides a large number of analysis tools, is easily extensible, and supports dif-
ferent model formats. The toolbox includes several computationally efficient analysis
methods, an interactive GUI for network visualization, a module for batch FBA simula-
tion, and a metabolite-centric view on flux distributions that is the first of its kind. The
Metano method of metabolite flux minimization uses a variability analysis approach to
minimize the fluxes through metabolite nodes. While other studies already pointed out the
importance of metabolite fluxes, e.g., for drug discovery, we implemented this approach in
a comprehensive toolbox.
Metano is extended by MMTB, a web-based toolbox for metabolic modeling. MMTB
integrates EnzymeDetector annotations and biochemical reactions from different databases
to assist during model creation. Web-based analyses, for example, FBA, FVA, MFM, and
split-ratio analysis, allow users to analyze models without a local installation. An intuitive
user interface introduces inexperienced users to stoichiometric modeling. In addition, a
modeling platform drives the reuse of models and guides new users through the wide
landscape of existing models. Conversion tools for SBML and JSON models further support
this aspect. In contrast to well-established toolboxes, such as COBRA that provide many
advanced methods especially for metabolic engineering, MMTB focuses on usability and a
less experienced audience that want to effortlessly explore metabolic modeling, without
refraining from the accuracy or capability of a full-fledged modeling toolbox. We confirmed
the latter by applying Metano methods to the model iMG481 and comparing the results
with published analyses.
Moreover, we applied Metano methods to the published model of C. glutamicum
DSM 20300. We were able to evaluate the accuracy and reliability of Metano methods
by reproducing results from the primary literature. Furthermore, we applied Metano
methods to create and elucidate a metabolic model of P. inhibens DSM 17395. We were
able to simulate both the metabolic versatility and the growth-inhibiting effect of TDA.
Furthermore, metabolite-centric analyses and visualizations highlighted metabolic fluxes
that contribute to carbon loss and growth inhibition.
4. Materials and Methods
4.1. Strains and Growth Conditions
In this study, P. inhibens DSM 17395, its plasmid-cured derivative strain ∆262-kb [19]
and the transposon mutant strain tdaE [20] were used. All cultivations were performed
in a defined saltwater medium [14] with single amino acids as C-equivalent, sole carbon
source: 30 mM L-alanine, 10 mM L-phenylalanine, or 15 mM L-leucine.
Cultivations were started in 20 mL saltwater medium containing 1% casamino acids
(Merck, Darmstadt, Germany), and cells were transferred at least for one adaptation cycle
in the respective amino acid before inoculating the main cultures. All main experiments
were conducted with three biological replicates in 500 mL Erlenmeyer flasks with three
baffles at 150 rpm and 28 ◦C in an orbital incubator as previously described [20].
To make sure that oxygen is not limited, dissolved oxygen was measured with an
online oxygen monitoring device (Shake Flask Reader; PreSens, Regensburg, Germany) as
previously described [20]. For determination of the biomass composition, six biological
replicates of each strain were cultivated with each single amino acid. Growing cells were
harvested and centrifuged at 4 ◦C and 12,000× g for 5 min. Cells were re-suspended in 3.7%
sodium chloride and split to get 1–3 mg cell dry weight (CDW) for DNA, RNA, protein
and polyhydroxybutyrate (PHB) each, 10–30 mg for lipid and 10–30 mg for determination
of CDW (Supplementary Tables S3 and S4).
4.2. The Metabolic Model iMG481
The metabolic model iMG481 was obtained from the Supplemental Material of Graf
and colleagues [45]. The model is a modified version of iEZ475 [47], that is in turn a
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modified version of iKK446 [48]. It was converted into the Metano reaction format using
the SBML conversion tool of MMTB. The model was furthermore distributed by uploading
it to the MMTB model platform under the terms of the Creative Commons Attribution
License (CC-BY). FBA was performed using maximum biomass yield as objective function.
4.3. Reconstruction of the Metabolic Model iPin571
The metabolic model iPin571 was reconstructed based on genome and experimental
data [10–15,17,18,46]. The web tool MMTB presented here was used for model reconstruction
and validation. The model was built bottom-up using the pathway search of MMTB.
All pathways for biomass production and degradation of various carbon sources were
checked using the built-in genome annotation score from EnzymeDetector [41]. We included
all necessary pathways into the model and matched gene locus tags using the UniProt
accessions that were given by MMTB (Supplementary Table S1). The biomass composition
was experimentally determined (Supplementary Tables S3 and S4) and added as biomass
reaction for each strain and carbon source in the model. Flux balance analyses (FBA) were
performed with the presented Metano toolbox. For analysis of the carbon flux distribution,
the upper bound of the biomass reaction flux was set to the experimentally determined
growth rate. FBA was performed using maximum biomass yield as objective function.
4.4. Algorithm
Metano is a software toolbox for metabolic modeling implemented in the Python
programming language. Metano is easily extensible by prospective functional extensions
via well-documented interfaces in a structured object-oriented framework. This allows
the adaptation of the software to different requirements by users with basic programming
skills. Additionally, all functionalities of Metano can be accessed by standalone Python
programs via the command line, without the need to write programs.
The Metano toolbox implements many well-established analysis tools, including
FBA, FVA, MOMA, knockout simulation, and dead-end analysis [49]. Advanced features
include tools for split-ratio analysis and metabolite flux minimization (MFM) [29], FBA
batch computation, a prediction tool for directionality from Gibbs free energies, automated
plausibility checking of metabolic models, and the generation of comparative scatter plots.
MFM first performs a standard FBA and then adds a variability analysis comparable
to FVA by the following algorithm: (1) Set a constraint for the objective function (default
95% of FBA flux). (2) Generate coefficient vectors expressing the (producing) metabolite
fluxes as linear combinations of the reaction fluxes. (3) Perform linear programming with
the linear objective functions defined by these coefficient vectors to successively minimize
each objective function.
Split-ratio analysis computes the split ratios for the fluxes entering and leaving each
metabolite as totals fluxes and percentage values. This method is used to calculate the
network and label edges and nodes for the visualization available at MMTB.
All methods are described in more detail on the software website and in the Sup-
plementary Appendix. Additionally, the documented source code is available online:
github.com/JuliaHelmecke/metano (accessed on 9 Febraury 2021).
Metano includes interfaces to numerous freely available solvers for mathematical
optimization problems. For linear programming, the supported solvers are lp-solve and the
GNU Linear Programming Kit (GLPK), interfaced to Python via Swiglpk and PyMathProg,
respectively. Quadratic programming problems are solved by using the quadratic cone
program solver of CVXOPT, interfaced via CVXPY.
The software is published under the GNU General Public License version 3 and is
available via the MMTB website (mmtb.brenda-enzymes.org (accessed on 9 Febraury 2021)).
Metano does not rely on commercial software packages and can be installed on various Linux
distributions via the Python Package Index (PyPI) and the related package installation system
pip. A current version of Metano is also available for OS-independent use as a Docker image
on Docker Hub.
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documentation of Metano, including use instructions, algorithms, and examples.
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